NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

C反應性蛋白質(CRP)的全球市場:市場規模·佔有率·趨勢分析

C-Reactive Protein Testing Market Size, Share & Trends Analysis Report By Assay Type, By Detection Range, By Disease Area (Cancer, Endometriosis, Cardiovascular Diseases), By End Use, And Segment Forecasts, 2020 - 2027

出版商 Grand View Research, Inc. 商品編碼 640077
出版日期 內容資訊 英文 190 Pages
商品交期: 2-10個工作天內
價格
C反應性蛋白質(CRP)的全球市場:市場規模·佔有率·趨勢分析 C-Reactive Protein Testing Market Size, Share & Trends Analysis Report By Assay Type, By Detection Range, By Disease Area (Cancer, Endometriosis, Cardiovascular Diseases), By End Use, And Segment Forecasts, 2020 - 2027
出版日期: 2020年02月19日內容資訊: 英文 190 Pages
簡介

本報告提供全球C反應性蛋白質(CRP)市場調查,提供市場概要,各化驗類型·檢測範圍·治療領域·終端用戶·各地區的市場規模的變化與預測,市場成長要素及阻礙因素,市場機會,市場佔有率,競爭情形,主要企業的簡介等全面性資訊。

目錄

第1章 摘要整理

第2章 調查手法

  • 資訊採購
  • 資料分析
  • 市場定式化與檢驗
  • 模式詳細內容
  • 2次資料
  • 1次資料
  • 調查目的

第3章 市場變數·趨勢·範圍

  • 市場動態
  • 市場機會分析
  • 威脅分析
  • 普及率與成長預測
  • SWOT分析
  • 波特的五力分析

第4章 全球C反應性蛋白質(CRP)市場:各化驗類型

  • 市場趨勢分析:各化驗類型
    • ELISA
      • 臨床ELISA
      • 非臨床ELISA
    • 化學冷光免疫測量
    • 其他

第5章 全球C反應性蛋白質(CRP)市場:各檢測範圍

  • 市場趨勢分析:各檢測範圍
    • 高敏感度C反應性蛋白質(hsCRP)
    • 傳統C反應性蛋白質
    • 心臟用C反應性蛋白質(cCRP)

第6章 全球C反應性蛋白質(CRP)市場:各治療領域

  • 市場趨勢分析:各治療領域
    • 心血管疾病
    • 癌症
    • 類風濕性關節炎
    • 發炎性腸道疾病
    • 子宮內膜異位症
    • 狼瘡
    • 其他

第7章 全球C反應性蛋白質(CRP)市場:各終端用戶

  • 市場趨勢分析:各終端用戶
    • 診療所
    • 醫院
    • 研究所
    • 附看護住宅
    • 家庭

第8章 全球C反應性蛋白質(CRP)市場:各地區

  • 市場趨勢分析:各地區
    • 北美
    • 歐洲
    • 亞太地區
    • 南美
    • 中東·非洲

第9章 競爭情形

  • 企業類別
  • 企業的市場定位
  • 主要企業
  • 策略架構
  • 企業簡介
    • Thermo Fisher Scientific, Inc.
    • F. Hoffmann-La Roche Ltd.
    • Danaher
    • Quest Diagnostics Incorporated
    • Siemens
    • Abbott Laboratories
    • Laboratory Corporation of America Holdings (LabCorp)
    • Merck KGaA
    • Abaxis, Inc.
    • Ortho Clinical Diagnostics
    • Getein Biotech, Inc.
    • 堀場製作所
    • Randox Laboratories Ltd.
    • BODITECH MED, INC
    • Aidian
    • Eurolyser Diagnostica GmbH
    • Abcam plc
    • Bio-Techne
    • EKF Diagnostics
    • SD Biosensor, INC.
目錄
Product Code: GVR-2-68038-129-0

The global C-reactive protein testing market size is expected to reach USD 1.9 billion by 2027, growing at a CAGR of 1.3% during the forecast period, according to a new report by Grand View Research, Inc. Several studies have shown the role of C-reactive proteins as an inflammatory marker in gastrointestinal diseases. This has accelerated the reliance on these proteins for the diagnosis of a disease like Crohn's disease and acute pancreatitis. The initiatives undertaken by government agencies to increase awareness as well as uptake of point-of-care are factors driving the market.

The rising prevalence of gastrointestinal diseases coupled with subsequent demand for robust disease testing protocols has driven the market to a considerable extent. POC based CRP testing within healthcare settings and among patients drives market growth. For instance, the National Institute for Health and Care Excellence has recommended the usage of POC CRP testing in primary care for adult patients diagnosed with respiratory tract infections.

Increase in funds and investments for research entities that are engaged in performing research activities in this area, boost market progression. The National Institute for Health Research, the Wellcome Trust, and the Department for International Development are among the few funding agencies engaged in supporting C-reactive protein tests related research activities.

Further key findings from the report suggest:

Immunoturbidimetric assay segment accounted for the maximum revenue share in 2019 and is anticipated to maintain its dominance during the forecast period

This is attributive to the introduction of less expensive automated and highly sensitive immunoturbidimetric assays that have a wide measuring range for CRP levels

High sensitivity C-reactive protein accounted for the major revenue share in 2019 owing to their efficiency in delivering results with high accuracy as compared to the conventional assays

CRP is one of the important biomarkers that play a direct role in promoting vessel damage, vascular inflammation, and other clinical cardiovascular events

This has resulted in the high adoption rate of these tests for the detection of cardiovascular diseases, as compared to other disease areas

The high usage rate of these tests within clinical settings is attributive to the largest revenue share of clinics due to an increase in the number of patient visits in clinics

The clinics, including physician offices, outpatient clinics, and community health centers conduct these tests at an affordable cost in minimal time, resulting in the largest share

North America dominated the C-reactive protein testing market due to the presence of agencies, such as the American College of Cardiology Foundation, which raises awareness for the preliminary screening of inflammatory disorders, thereby positively influencing the uptake of these tests

Asia Pacific is anticipated to witness the fastest CAGR owing to the ongoing research studies pertaining CRP testing in the Asian countries, which promotes the adoption of these tests in this region

Quest Diagnostics, Siemens, Danaher, Abbott, Roche, and Thermo Fisher Scientific are some key companies operating in the market

These companies are expanding their product portfolio and distribution network through partnership and agreement models to reinforce their market presence

For instance, in May 2018, Ortho Clinical Diagnostics signed an agreement with Sentinel Diagnostics to develop CRP Ultra (MP) Assay for future CRP testing in hospitals and laboratories.

Table of Contents

Chapter 1 Executive Summary

  • 1.1 Market Overview
  • 1.2 Market Segmentation & Scope
  • 1.3 Competitive Insights

Chapter 2 Research Methodology

  • 2.1 Information Procurement
    • 2.1.1 Purchased database:
    • 2.1.2 GVR's internal database
    • 2.1.3 Secondary sources:
    • 2.1.4 Primary research:
    • 2.1.5 Details of primary research
  • 2.2 Information or Data Analysis
    • 2.2.1 Data analysis models
  • 2.3 Market Formulation & Validation
  • 2.4 Model Details
    • 2.4.1 Commodity flow analysis (Model 1)
      • 2.4.1.1 Approach 1: Commodity flow approach
    • 2.4.2 Volume price analysis (Model 2)
      • 2.4.2.1 Approach 2: Volume price analysis
  • 2.5 List of Secondary Sources
  • 2.6 List of Primary Sources
  • 2.7 Objectives
    • 2.7.1 Objective 1
    • 2.7.2 Objective 2

Chapter 3 Market Variables, Trends & Scope

  • 3.1 Market Dynamics
    • 3.1.1 Market driver analysis
      • 3.1.1.1 Increasing R&D in the field of C-reactive protein testing
      • 3.1.1.2 Rising incidence of chronic disorders
    • 3.1.2 Market restraint analysis
      • 3.1.2.1 Availability of alternative disease testing methods
  • 3.2 Opportunity Analysis
    • 3.2.1 Technological advancements pertaining to conventional CRP tests
    • 3.2.2 Growing adoption of point-of-care tests
  • 3.3 Threat Analysis
    • 3.3.1 Threat analysis on conventional CRP tests
  • 3.4 Penetration & Growth Prospect Mapping for Assay Type, 2019
  • 3.5 C-reactive Protein (CRP) Testing Market-SWOT Analysis, By Factor (Political & Legal, Economic And Technological)
  • 3.6 IndustryAnalysis - Porter's

Chapter 4 C-reactive Protein (CRP) Testing Market: Assay Type Estimates & Trend Analysis

  • 4.1 C-Reactive Protein Testing Market: Assay Type Movement Analysis
  • 4.2 Immunoturbidimetric Assay
    • 4.2.1 Global immunoturbidimetric assay market, 2016 - 2027 (USD Million)
  • 4.3 ELISA
    • 4.3.1 Global ELISA market, 2016 - 2027 (USD Million)
    • 4.3.2 Clinical ELISA
      • 4.3.2.1 Global clinical ELISA market, 2016 - 2027 (USD Million)
    • 4.3.3 Nonclinical ELISA
      • 4.3.3.1 Global nonclinical ELISA market, 2016 - 2027 (USD Million)
  • 4.4 Chemiluminescence Immunoassay
    • 4.4.1 Global Chemiluminescence Immunoassay market, 2016 - 2027 (USD Million)
  • 4.5 Others
    • 4.5.1 Global other assay types market, 2016 - 2027 (USD Million)

Chapter 5 C-reactive Protein (CRP) Testing Market: Detection Range Estimates & Trend Analysis

  • 5.1 C-Reactive Protein Testing Market: Detection Range Movement Analysis
  • 5.2 High Sensitivity C-reactive Protein (hs-CRP)
    • 5.2.1 Global hsCRP market, 2016 - 2027 (USD Million)
  • 5.3 Conventional CRP
    • 5.3.1 Global conventional CRP market, 2016 - 2027 (USD Million)
  • 5.4 Cardiac CRP (cCRP)
    • 5.4.1 Global cardiac CRP market, 2016 - 2027 (USD Million)

Chapter 6 C-reactive Protein (CRP) Testing Market: Disease Area Estimates & Trend Analysis

  • 6.1 C-Reactive Protein Testing Market: Disease Area Movement Analysis
  • 6.2 Cardiovascular Diseases
    • 6.2.1 Global cardiovascular diseases CRP testing market, 2016 - 2027 (USD Million)
  • 6.3 Cancer
    • 6.3.1 Global cancer CRP testing market, 2016 - 2027 (USD Million)
  • 6.4 Rheumatoid Arthritis
    • 6.4.1 Global rheumatoid arthritis CRP testing market, 2016 - 2027 (USD Million)
  • 6.5 Inflammatory Bowel Disease
    • 6.5.1 Global inflammatory bowel disease CRP testing market, 2016 - 2027 (USD Million)
  • 6.6 Endometriosis
    • 6.6.1 Global endometriosis CRP testing market, 2016 - 2027 (USD Million)
  • 6.7 Lupus
    • 6.7.1 Global lupus CRP testing market, 2016 - 2027 (USD Million)
  • 6.8 Others
    • 6.8.1 Global others market, 2016 - 2027 (USD Million)

Chapter 7 C-reactive Protein (CRP) Testing Market: End-use Estimates & Trend Analysis

  • 7.1 C-Reactive Protein Testing Market: End-use Movement Analysis
  • 7.2 Clinics
    • 7.2.1 Global clinics market, 2016 - 2027 (USD Million)
    • 7.2.2 Clinics, by entity
      • 7.2.2.1 Physician offices
      • 7.2.2.1.1 Global physician offices market, 2016 - 2027 (USD Million)
      • 7.2.2.2 Small clinics
      • 7.2.2.2.1 Global small clinics market, 2016 - 2027 (USD Million)
      • 7.2.2.3 Others
      • 7.2.2.3.1 Global other clinics market, 2016 - 2027 (USD Million)
    • 7.2.3 Clinics, by settings
      • 7.2.3.1 Urban settings
      • 7.2.3.1.1 Global urban setting clinics market, 2016 - 2027 (USD Million)
      • 7.2.3.2 Rural settings
      • 7.2.3.2.1 Global rural settings clinic market, 2016 - 2027 (USD Million)
  • 7.3 Hospitals
    • 7.3.1 Global hospitals market, 2016 - 2027 (USD Million)
    • 7.3.2 Urban setting
      • 7.3.2.1 Global urban setting hospitals market, 2016 - 2027 (USD Million)
    • 7.3.3 Rural setting
      • 7.3.3.1 Global rural setting hospitals market, 2016 - 2027 (USD Million)
  • 7.4 Laboratories
    • 7.4.1 Global laboratories market, 2016 - 2027 (USD Million)
    • 7.4.2 Urban setting
      • 7.4.2.1 Global urban setting laboratories market, 2016 - 2027 (USD Million)
    • 7.4.3 Rural setting
      • 7.4.3.1 Global rural setting laboratories market, 2016 - 2027 (USD Million)
  • 7.5 Assisted Living Healthcare Facilities
    • 7.5.1 Global assisted living healthcare facilities market, 2016 - 2027 (USD Million)
    • 7.5.2 Urban setting
      • 7.5.2.1 Global urban setting assisted living healthcare facilities market, 2016 - 2027 (USD Million)
    • 7.5.3 Rural setting
      • 7.5.3.1 Global rural setting assisted living healthcare facilities market, 2016 - 2027 (USD Million)
  • 7.6 Home
    • 7.6.1 Global home market, 2016 - 2027 (USD Million)
  • 7.7 Others
    • 7.7.1 Global others market, 2016 - 2027 (USD Million)

Chapter 8 C-reactive Protein (CRP) Testing Market: Regional Estimates & Trend Analysis by Assay, Detection Area, Disease Area, & End-use

  • 8.1 C-Reactive Protein Testing Market Share by Region, 2019 & 2027
  • 8.2 North America
    • 8.2.1 North America C-reactive protein testing market, 2016 - 2027 (USD Million)
    • 8.2.2 U.S.
      • 8.2.2.1 U.S. C-reactive protein testing market, by assay type, 2016 - 2027 (USD Million)
      • 8.2.2.2 U.S. C-reactive protein testing market, by detection range, 2016 - 2027 (USD Million)
      • 8.2.2.3 U.S. C-reactive protein testing market, by disease area, 2016 - 2027 (USD Million)
      • 8.2.2.4 U.S. C-reactive protein testing market, by end use, 2016 - 2027 (USD Million)
    • 8.2.3 Canada
      • 8.2.3.1 Canada C-reactive protein testing market, by assay type, 2016 - 2027 (USD Million)
      • 8.2.3.2 Canada C-reactive protein testing market, by detection range, 2016 - 2027 (USD Million)
      • 8.2.3.3 Canada C-reactive protein testing market, by disease area, 2016 - 2027 (USD Million)
      • 8.2.3.4 Canada C-reactive protein testing market, by end use, 2016 - 2027 (USD Million)
  • 8.3 Europe
    • 8.3.1 Europe C-reactive protein testing market, 2016 - 2027 (USD Million)
    • 8.3.2 Germany
      • 8.3.2.1 Germany C-reactive protein testing market, by assay type, 2016 - 2027 (USD Million)
      • 8.3.2.2 Germany C-reactive protein testing market, by detection range, 2016 - 2027 (USD Million)
      • 8.3.2.3 Germany C-reactive protein testing market, by disease area, 2016 - 2027 (USD Million)
      • 8.3.2.4 Germany C-reactive protein testing market, by end use, 2016 - 2027 (USD Million)
    • 8.3.3 U.K.
      • 8.3.3.1 U.K. C-reactive protein testing market, by assay type, 2016 - 2027 (USD Million)
      • 8.3.3.2 U.K. C-reactive protein testing market, by detection range, 2016 - 2027 (USD Million)
      • 8.3.3.3 U.K. C-reactive protein testing market, by disease area, 2016 - 2027 (USD Million)
      • 8.3.3.4 U.K. C-reactive protein testing market, by end use, 2016 - 2027 (USD Million)
  • 8.4 Asia Pacific
    • 8.4.1 Asia Pacific C-reactive protein testing market, 2016 - 2027 (USD Million)
    • 8.4.2 Japan
      • 8.4.2.1 Japan C-reactive protein testing market, by assay type, 2016 - 2027 (USD Million)
      • 8.4.2.2 Japan C-reactive protein testing market, by detection range, 2016 - 2027 (USD Million)
      • 8.4.2.3 Japan C-reactive protein testing market, by disease area, 2016 - 2027 (USD Million)
      • 8.4.2.4 Japan C-reactive protein testing market, by end use, 2016 - 2027 (USD Million)
    • 8.4.3 China
      • 8.4.3.1 China C-reactive protein testing market, by assay type, 2016 - 2027 (USD Million)
      • 8.4.3.2 China C-reactive protein testing market, by detection range, 2016 - 2027 (USD Million)
      • 8.4.3.3 China C-reactive protein testing market, by disease area, 2016 - 2027 (USD Million)
      • 8.4.3.4 China C-reactive protein testing market, by end use, 2016 - 2027 (USD Million)
  • 8.5 Latin America
    • 8.5.1 Latin America C-reactive protein testing market, 2016 - 2027 (USD Million)
    • 8.5.2 Brazil
      • 8.5.2.1 Brazil C-reactive protein testing market, by assay type, 2016 - 2027 (USD Million)
      • 8.5.2.2 Brazil C-reactive protein testing market, by detection range, 2016 - 2027 (USD Million)
      • 8.5.2.3 Brazil C-reactive protein testing market, by disease area, 2016 - 2027 (USD Million)
      • 8.5.2.4 Brazil C-reactive protein testing market, by end use, 2016 - 2027 (USD Million)
  • 8.6 Middle East & Africa (MEA)
    • 8.6.1 Middle East & Africa C-reactive protein testing market, 2016 - 2027 (USD Million)
    • 8.6.2 South Africa
      • 8.6.2.1 South Africa C-reactive protein testing market, by assay type, 2016 - 2027 (USD Million)
      • 8.6.2.2 South Africa C-reactive protein testing market, by detection range, 2016 - 2027 (USD Million)
      • 8.6.2.3 South Africa C-reactive protein testing market, by disease area, 2016 - 2027 (USD Million)
      • 8.6.2.4 South Africa C-reactive protein testing market, by end use, 2016 - 2027 (USD Million)

Chapter 9 Competitive Landscape

  • 9.1 Company Categorization
  • 9.2 Recent Developments & Impact Analysis, by Key Market Participants
  • 9.3 Public Companies
    • 9.3.1 Company market position analysis
  • 9.4 Private Companies
    • 9.4.1 List of key emerging companies
  • 9.5 Strategy Framework
  • 9.6 Company Profiles
    • 9.6.1 Thermo Fisher Scientific, Inc.
      • 9.6.1.1 Company overview
      • 9.6.1.2 Financial performance
      • 9.6.1.3 Product benchmarking
      • 9.6.2.4 Strategic initiatives
    • 9.6.2 F. Hoffmann-La Roche Ltd.
      • 9.6.2.1 Company overview
      • 9.6.2.2 Financial performance
      • 9.6.2.3 Product benchmarking
      • 9.6.2.4 Strategic initiatives
    • 9.6.3 Danaher
      • 9.6.3.1 Company overview
      • 9.6.3.1.1 Beckman Coulter, Inc.
      • 9.6.3.1.2 Radiometer
      • 9.6.3.2 Financial performance
      • 9.6.3.3 Product benchmarking
      • 9.6.3.4 Strategic initiatives
    • 9.6.4 Quest Diagnostics Incorporated
      • 9.6.4.1 Company overview
      • 9.6.4.2 Financial performance
      • 9.6.4.3 Product benchmarking
      • 9.6.4.4 Strategic initiatives
    • 9.6.5 Siemens
      • 9.6.5.1 Company overview
      • 9.6.5.2 Financial performance
      • 9.6.5.3 Product benchmarking
      • 9.6.5.4 Strategic initiatives
    • 9.6.6 Abbott Laboratories
      • 9.6.5.1 Company overview
      • 9.6.6.1.1 Alere Inc.
      • 9.6.6.2 Financial performance
      • 9.6.6.3 Product benchmarking
      • 9.6.6.4 Strategic initiatives
    • 9.6.7 Laboratory Corporation of America Holdings (LabCorp)
      • 9.6.7.1 Company overview
      • 9.6.7.2 Financial performance
      • 9.6.7.3 Product benchmarking
      • 9.6.7.4 Strategic initiatives
    • 9.6.8 Merck KGaA
      • 9.6.8.1 Company overview
      • 9.6.8.1.1 Sigma-Aldrich Co. LLC
      • 9.6.8.1.2 Merck Millipore
      • 9.6.8.2 Financial performance
      • 9.6.8.3 Product benchmarking
      • 9.6.8.4 Strategic initiatives
    • 9.6.9 Abaxis, Inc.
      • 9.6.9.1 Company overview
      • 9.6.9.2 Financial performance
      • 9.6.9.3 Product benchmarking
      • 9.6.9.4 Strategic initiatives
    • 9.6.10 Ortho Clinical Diagnostics
      • 9.6.10.1 Company overview
      • 9.6.10.2 Financial performance
      • 9.6.10.3 Product benchmarking
      • 9.6.10.4 Strategic initiatives
    • 9.6.11 Getein Biotech, Inc.
      • 9.6.11.1 Company overview
      • 9.6.11.2 Financial performance
      • 9.6.11.3 Product benchmarking
    • 9.6.12 HORIBA, Ltd.
      • 9.6.12.1 Company overview
      • 9.6.12.2 Financial performance
      • 9.6.12.3 Product benchmarking
      • 9.6.12.4 Strategic initiatives
    • 9.6.13 Randox Laboratories Ltd.
      • 9.6.13.1 Company overview
      • 9.6.13.2 Financial performance
      • 9.6.13.3 Product benchmarking
      • 9.6.13.4 Strategic initiatives
    • 9.6.14 BODITECH MED, INC
      • 9.6.14.1 Company overview
      • 9.6.14.2 Financial performance
      • 9.6.14.3 Product benchmarking
      • 9.6.14.4 Strategic initiatives
    • 9.6.15 Aidian
      • 9.6.15.1 Company overview
      • 9.6.15.2 Financial performance
      • 9.6.15.3 Product benchmarking
      • 9.6.15.4 Strategic initiatives
    • 9.6.16 Eurolyser Diagnostica GmbH
      • 9.6.16.1 Company overview
      • 9.6.16.2 Financial performance
      • 9.6.16.3 Product benchmarking
      • 9.6.16.4 Strategic initiatives
    • 9.6.17 Abcam plc
      • 9.6.17.1 Company overview
      • 9.6.17.2 Financial performance
      • 9.6.17.3 Product benchmarking
      • 9.6.17.4 Strategic initiatives
    • 9.6.18 Bio-Techne
      • 9.6.18.1 Company overview
      • 9.6.18.2 Financial performance
      • 9.6.18.3 Product benchmarking
      • 9.6.18.4 Strategic initiatives
    • 9.6.19 EKF Diagnostics
      • 9.6.19.1 Company overview
      • 9.6.19.2 Financial performance
      • 9.6.19.3 Product benchmarking
      • 9.6.19.4 Strategic initiatives
    • 9.6.20 SD Biosensor, INC.
      • 9.6.20.1 Company overview
      • 9.6.20.2 Financial performance
      • 9.6.20.3 Product benchmarking
      • 9.6.20.4 Strategic initiatives

List of Tables

  • TABLE 1 List of secondary sources
  • TABLE 2 Chances of heart diseases associated with CRP levels in blood
  • TABLE 3 Estimated new female cases of breast cancer & deaths in the U.S., 2017
  • TABLE 4 North America C-reactive protein testing market, by assay type, 2016 - 2027 (USD Million)
  • TABLE 5 North America C-reactive protein testing market for ELISA, by type, 2016 - 2027 (USD Million)
  • TABLE 6 North America C-reactive protein testing market, by detection range, 2016 - 2027 (USD Million)
  • TABLE 7 North America C-reactive protein testing market, by disease area, 2016 - 2027 (USD Million)
  • TABLE 8 North America C-reactive protein testing market, by end use, 2016 - 2027 (USD Million)
  • TABLE 9 North America C-reactive protein testing market for clinics, by entity type, 2016 - 2027 (USD Million)
  • TABLE 10 North America C-reactive protein testing market for clinics, by setting type, 2016 - 2027 (USD Million)
  • TABLE 11 North America C-reactive protein testing market for hospital, by setting type, 2016 - 2027 (USD Million)
  • TABLE 12 North America C-reactive protein testing market for laboratories, by setting type, 2016 - 2027 (USD Million)
  • TABLE 13 North America C-reactive protein testing market for assisted living healthcare facilities, by setting type, 2016 - 2027 (USD Million)
  • TABLE 14 U.S. C-reactive protein testing market, by assay type, 2016 - 2027 (USD Million)
  • TABLE 15 U.S. C-reactive protein testing market for ELISA, by type, 2016 - 2027 (USD Million)
  • TABLE 16 U.S. C-reactive protein testing market, by detection range, 2016 - 2027 (USD Million)
  • TABLE 17 U.S. C-reactive protein testing market, by disease area, 2016 - 2027 (USD Million)
  • TABLE 18 U.S. C-reactive protein testing market, by end use, 2016 - 2027 (USD Million)
  • TABLE 19 U.S. C-reactive protein testing market for clinics, by entity type, 2016 - 2027 (USD Million)
  • TABLE 20 U.S. C-reactive protein testing market for clinics, by setting type, 2016 - 2027 (USD Million)
  • TABLE 21 U.S. C-reactive protein testing market for hospital, by setting type, 2016 - 2027 (USD Million)
  • TABLE 22 U.S. C-reactive protein testing market for laboratories, by setting type, 2016 - 2027 (USD Million)
  • TABLE 23 U.S. C-reactive protein testing market for assisted living healthcare facilities, by setting type, 2016 - 2027 (USD Million)
  • TABLE 24 Canada C-reactive protein testing market, by assay type, 2016 - 2027 (USD Million)
  • TABLE 25 Canada C-reactive protein testing market for ELISA, by type, 2016 - 2027 (USD Million)
  • TABLE 26 Canada C-reactive protein testing market, by detection range, 2016 - 2027 (USD Million)
  • TABLE 27 Canada C-reactive protein testing market, by disease area, 2016 - 2027 (USD Million)
  • TABLE 28 Canada C-reactive protein testing market, by end use, 2016 - 2027 (USD Million)
  • TABLE 29 Canada C-reactive protein testing market for clinics, by entity type, 2016 - 2027 (USD Million)
  • TABLE 30 Canada C-reactive protein testing market for clinics, by setting type, 2016 - 2027 (USD Million)
  • TABLE 31 Canada C-reactive protein testing market for hospital, by setting type, 2016 - 2027 (USD Million)
  • TABLE 32 Canada C-reactive protein testing market for laboratories, by setting type, 2016 - 2027 (USD Million)
  • TABLE 33 Canada C-reactive protein testing market for assisted living healthcare facilities, by setting type, 2016 - 2027 (USD Million)
  • TABLE 34 Europe C-reactive protein testing market, by assay type, 2016 - 2027 (USD Million)
  • TABLE 35 Europe C-reactive protein testing market for ELISA, by type, 2016 - 2027 (USD Million)
  • TABLE 36 Europe C-reactive protein testing market, by detection range, 2016 - 2027 (USD Million)
  • TABLE 37 Europe C-reactive protein testing market, by disease area, 2016 - 2027 (USD Million)
  • TABLE 38 Europe C-reactive protein testing market, by end-use, 2016 - 2027 (USD Million)
  • TABLE 39 Europe C-reactive protein testing market for clinics, by entity type, 2016 - 2027 (USD Million)
  • TABLE 40 Europe C-reactive protein testing market for clinics, by setting type, 2016 - 2027 (USD Million)
  • TABLE 41 Europe C-reactive protein testing market for hospital, by setting type, 2016 - 2027 (USD Million)
  • TABLE 42 Europe C-reactive protein testing market for laboratories, by setting type, 2016 - 2027 (USD Million)
  • TABLE 43 Europe C-reactive protein testing market for assisted living healthcare facilities, by setting type, 2016 - 2027 (USD Million)
  • TABLE 44 Germany C-reactive protein testing market, by assay type, 2016 - 2027 (USD Million)
  • TABLE 45 Germany C-reactive protein testing market for ELISA, by type, 2016 - 2027 (USD Million)
  • TABLE 46 Germany C-reactive protein testing market, by detection range, 2016 - 2027 (USD Million)
  • TABLE 47 Germany C-reactive protein testing market, by disease area, 2016 - 2027 (USD Million)
  • TABLE 48 Germany C-reactive protein testing market, by end use, 2016 - 2027 (USD Million)
  • TABLE 49 Germany C-reactive protein testing market for clinics, by entity type, 2016 - 2027 (USD Million)
  • TABLE 50 Germany C-reactive protein testing market for clinics, by setting type, 2016 - 2027 (USD Million)
  • TABLE 51 Germany C-reactive protein testing market for hospital, by setting type, 2016 - 2027 (USD Million)
  • TABLE 52 Germany C-reactive protein testing market for laboratories, by setting type, 2016 - 2027 (USD Million)
  • TABLE 53 Germany C-reactive protein testing market for assisted living healthcare facilities, by setting type, 2016 - 2027 (USD Million)
  • TABLE 54 U.K. C-reactive protein testing market, by assay type, 2016 - 2027 (USD Million)
  • TABLE 55 U.K. C-reactive protein testing market for ELISA, by type, 2016 - 2027 (USD Million)
  • TABLE 56 U.K. C-reactive protein testing market, by detection range, 2016 - 2027 (USD Million)
  • TABLE 57 U.K. C-reactive protein testing market, by disease area, 2016 - 2027 (USD Million)
  • TABLE 58 U.K. C-reactive protein testing market, by end use, 2016 - 2027 (USD Million)
  • TABLE 59 U.K. C-reactive protein testing market for clinics, by entity type, 2016 - 2027 (USD Million)
  • TABLE 60 U.K. C-reactive protein testing market for clinics, by setting type, 2016 - 2027 (USD Million)
  • TABLE 61 U.K. C-reactive protein testing market for hospital, by setting type, 2016 - 2027 (USD Million)
  • TABLE 62 U.K. C-reactive protein testing market for laboratories, by setting type, 2016 - 2027 (USD Million)
  • TABLE 63 U.K. C-reactive protein testing market for assisted living healthcare facilities, by setting type, 2016 - 2027 (USD Million)
  • TABLE 64 Asia Pacific C-reactive protein testing market, by assay type, 2016 - 2027 (USD Million)
  • TABLE 65 Asia Pacific C-reactive protein testing market for ELISA, by type, 2016 - 2027 (USD Million)
  • TABLE 66 Asia Pacific C-reactive protein testing market, by detection range, 2016 - 2027 (USD Million)
  • TABLE 67 Asia Pacific C-reactive protein testing market, by disease area, 2016 - 2027 (USD Million)
  • TABLE 68 Asia Pacific C-reactive protein testing market, by end use, 2016 - 2027 (USD Million)
  • TABLE 69 Asia Pacific C-reactive protein testing market for clinics, by entity type, 2016 - 2027 (USD Million)
  • TABLE 70 Asia Pacific C-reactive protein testing market for clinics, by setting type, 2016 - 2027 (USD Million)
  • TABLE 71 Asia Pacific C-reactive protein testing market for hospital, by setting type, 2016 - 2027 (USD Million)
  • TABLE 72 Asia Pacific C-reactive protein testing market for laboratories, by setting type, 2016 - 2027 (USD Million)
  • TABLE 73 Asia Pacific C-reactive protein testing market for assisted living healthcare facilities, by setting type, 2016 - 2027 (USD Million)
  • TABLE 74 Japan C-reactive protein testing market, by assay type, 2016 - 2027 (USD Million)
  • TABLE 75 Japan C-reactive protein testing market for ELISA, by type, 2016 - 2027 (USD Million)
  • TABLE 76 Japan C-reactive protein testing market, by detection range, 2016 - 2027 (USD Million)
  • TABLE 77 Japan C-reactive protein testing market, by disease area, 2016 - 2027 (USD Million)
  • TABLE 78 Japan C-reactive protein testing market, by end use, 2016 - 2027 (USD Million)
  • TABLE 79 Japan C-reactive protein testing market for clinics, by entity type, 2016 - 2027 (USD Million)
  • TABLE 80 Japan C-reactive protein testing market for clinics, by setting type, 2016 - 2027 (USD Million)
  • TABLE 81 Japan C-reactive protein testing market for hospital, by setting type, 2016 - 2027 (USD Million)
  • TABLE 82 Japan C-reactive protein testing market for laboratories, by setting type, 2016 - 2027 (USD Million)
  • TABLE 83 Japan C-reactive protein testing market for assisted living healthcare facilities, by setting type, 2016 - 2027 (USD Million)
  • TABLE 84 China C-reactive protein testing market, by assay type, 2016 - 2027 (USD Million)
  • TABLE 85 China C-reactive protein testing market for ELISA, by type, 2016 - 2027 (USD Million)
  • TABLE 86 China C-reactive protein testing market, by detection range, 2016 - 2027 (USD Million)
  • TABLE 87 China C-reactive protein testing market, by disease area, 2016 - 2027 (USD Million)
  • TABLE 88 China C-reactive protein testing market, by end use, 2016 - 2027 (USD Million)
  • TABLE 89 China C-reactive protein testing market for clinics, by entity type, 2016 - 2027 (USD Million)
  • TABLE 90 China C-reactive protein testing market for clinics, by setting type, 2016 - 2027 (USD Million)
  • TABLE 91 China C-reactive protein testing market for hospital, by setting type, 2016 - 2027 (USD Million)
  • TABLE 92 China C-reactive protein testing market for laboratories, by setting type, 2016 - 2027 (USD Million)
  • TABLE 93 China C-reactive protein testing market for assisted living healthcare facilities, by setting type, 2016 - 2027 (USD Million)
  • TABLE 94 Latin America C-reactive protein testing market, by assay type, 2016 - 2027 (USD Million)
  • TABLE 95 Latin America C-reactive protein testing market for ELISA, by type, 2016 - 2027 (USD Million)
  • TABLE 96 Latin America C-reactive protein testing market, by detection range, 2016 - 2027 (USD Million)
  • TABLE 97 Latin America C-reactive protein testing market, by disease area, 2016 - 2027 (USD Million)
  • TABLE 98 Latin America C-reactive protein testing market, by end use, 2016 - 2027 (USD Million)
  • TABLE 99 Latin America C-reactive protein testing market for clinics, by entity type, 2016 - 2027 (USD Million)
  • TABLE 100 Latin America C-reactive protein testing market for clinics, by setting type, 2016 - 2027 (USD Million)
  • TABLE 101 Latin America C-reactive protein testing market for hospital, by setting type, 2016 - 2027 (USD Million)
  • TABLE 102 Latin America C-reactive protein testing market for laboratories, by setting type, 2016 - 2027 (USD Million)
  • TABLE 103 Latin America C-reactive protein testing market for assisted living healthcare facilities, by setting type, 2016 - 2027 (USD Million)
  • TABLE 104 Brazil C-reactive protein testing market, by assay type, 2016 - 2027 (USD Million)
  • TABLE 105 Brazil C-reactive protein testing market for ELISA, by type, 2016 - 2027 (USD Million)
  • TABLE 106 Brazil C-reactive protein testing market, by detection range, 2016 - 2027 (USD Million)
  • TABLE 107 Brazil C-reactive protein testing market, by disease area, 2016 - 2027 (USD Million)
  • TABLE 108 Brazil C-reactive protein testing market, by end use, 2016 - 2027 (USD Million)
  • TABLE 109 Brazil C-reactive protein testing market for clinics, by entity type, 2016 - 2027 (USD Million)
  • TABLE 110 Brazil C-reactive protein testing market for clinics, by setting type, 2016 - 2027 (USD Million)
  • TABLE 111 Brazil C-reactive protein testing market for hospital, by setting type, 2016 - 2027 (USD Million)
  • TABLE 112 Brazil C-reactive protein testing market for laboratories, by setting type, 2016 - 2027 (USD Million)
  • TABLE 113 Brazil C-reactive protein testing market for assisted living healthcare facilities, by setting type, 2016 - 2027 (USD Million)
  • TABLE 114 MEA C-reactive protein testing market, by assay type, 2016 - 2027 (USD Million)
  • TABLE 115 MEA C-reactive protein testing market for ELISA, by type, 2016 - 2027 (USD Million)
  • TABLE 116 MEA C-reactive protein testing market, by detection range, 2016 - 2027 (USD Million)
  • TABLE 117 MEA C-reactive protein testing market, by disease area, 2016 - 2027 (USD Million)
  • TABLE 118 MEA C-reactive protein testing market, by end use, 2016 - 2027 (USD Million)
  • TABLE 119 MEA C-reactive protein testing market for clinics, by entity type, 2016 - 2027 (USD Million)
  • TABLE 120 MEA C-reactive protein testing market for clinics, by setting type, 2016 - 2027 (USD Million)
  • TABLE 121 MEA C-reactive protein testing market for hospital, by setting type, 2016 - 2027 (USD Million)
  • TABLE 122 MEA C-reactive protein testing market for laboratories, by setting type, 2016 - 2027 (USD Million)
  • TABLE 123 MEA C-reactive protein testing market for assisted living healthcare facilities, by setting type, 2016 - 2027 (USD Million)
  • TABLE 124 South Africa C-reactive protein testing market, by assay type, 2016 - 2027 (USD Million)
  • TABLE 125 South Africa C-reactive protein testing market for ELISA, by type, 2016 - 2027 (USD Million)
  • TABLE 126 South Africa C-reactive protein testing market, by detection range, 2016 - 2027 (USD Million)
  • TABLE 127 South Africa C-reactive protein testing market, by disease area, 2016 - 2027 (USD Million)
  • TABLE 128 South Africa C-reactive protein testing market, by end use, 2016 - 2027 (USD Million)
  • TABLE 129 South Africa C-reactive protein testing market for clinics, by entity type, 2016 - 2027 (USD Million)
  • TABLE 130 South Africa C-reactive protein testing market for clinics, by setting type, 2016 - 2027 (USD Million)
  • TABLE 131 South Africa C-reactive protein testing market for hospital, by setting type, 2016 - 2027 (USD Million)
  • TABLE 132 South Africa C-reactive protein testing market for laboratories, by setting type, 2016 - 2027 (USD Million)
  • TABLE 133 South Africa C-reactive protein testing market for assisted living healthcare facilities, by setting type, 2016 - 2027 (USD Million)
  • TABLE 134 List of key emerging companies

List of Figures

  • FIG. 1 Market research process
  • FIG. 2 Data triangulation techniques
  • FIG. 3 Primary research pattern
  • FIG. 4 Market research approaches
  • FIG. 5 Value chain-based sizing & forecasting
  • FIG. 6 QFD modelling for market share assessment
  • FIG. 7 Market formulation & validation
  • FIG. 8 Market summary
  • FIG. 9 Market trends & outlook
  • FIG. 10 Market segmentation & scope
  • FIG. 11 Market driver relevance analysis (Current & future impact)
  • FIG. 12 Market restraint relevance analysis (Current & future impact)
  • FIG. 13 Technology timeline: CRP detection
  • FIG. 14 Antibiotic prescribing decisions pre- and post-CRP tests in UCC study
  • FIG. 15 Penetration & growth prospect mapping for assay type, 2019
  • FIG. 16 SWOT Analysis, By Factor (political & legal, economic and technological)
  • FIG. 17 Porter's Five Forces Analysis
  • FIG. 18 Global C-reactive protein testing market: Assay type outlook key takeaways
  • FIG. 19 Global C-reactive protein testing market: Assay type movement analysis
  • FIG. 20 Global immunoturbidimetric assay market, 2016 - 2027 (USD Million)
  • FIG. 21 Global ELISA market, 2016 - 2027 (USD Million)
  • FIG. 22 Global clinical ELISA market, 2016 - 2027 (USD Million)
  • FIG. 23 Global nonclinical ELISA market, 2016 - 2027 (USD Million)
  • FIG. 24 Global chemiluminescence immunoassay market, 2016 - 2027 (USD Million)
  • FIG. 25 Global others market, 2016 - 2027 (USD Million)
  • FIG. 26 Global C-reactive protein testing market: Detection range estimates outlook key takeaways
  • FIG. 27 Global C-reactive protein testing market: Detection range movement analysis
  • FIG. 28 Global hsCRP market, 2016 - 2027 (USD Million)
  • FIG. 29 Global conventional CRP market, 2016 - 2027 (USD Million)
  • FIG. 30 Global cardiac CRP market, 2016 - 2027 (USD Million)
  • FIG. 31 Global C-reactive protein testing market: Disease area estimates outlook key takeaways
  • FIG. 32 Global C-reactive protein testing market: Disease Area movement analysis
  • FIG. 33 Global cardiovascular diseases CRP testing market, 2016 - 2027 (USD Million)
  • FIG. 34 Global cancer CRP testing market, 2016 - 2027 (USD Million)
  • FIG. 35 Global rheumatoid arthritis CRP testing market, 2016 - 2027 (USD Million)
  • FIG. 36 Global inflammatory bowel disease CRP testing market, 2016 - 2027 (USD Million)
  • FIG. 37 Global endometriosis CRP testing market, 2016 - 2027 (USD Million)
  • FIG. 38 Global lupus CRP testing market, 2016 - 2027 (USD Million)
  • FIG. 39 Global others market, 2016 - 2027 (USD Million)
  • FIG. 40 Global C-reactive protein testing market: End-use estimates outlook key takeaways
  • FIG. 41 Global C-reactive protein testing market: End-use movement analysis
  • FIG. 42 Global clinics market, 2016 - 2027 (USD Million)
  • FIG. 43 Physician office visits in the U.S., by age (Thousands)
  • FIG. 44 Global physician office market, 2016 - 2027 (USD Million)
  • FIG. 45 Global small clinic market, 2016 - 2027 (USD Million)
  • FIG. 46 Global other clinics market, 2016 - 2027 (USD Million)
  • FIG. 47 Global urban setting clinics market, 2016 - 2027 (USD Million)
  • FIG. 48 Global rural settings clinic market, 2016 - 2027 (USD Million)
  • FIG. 49 Global hospitals market, 2016 - 2027 (USD Million)
  • FIG. 50 Global urban setting hospitals market, 2016 - 2027 (USD Million)
  • FIG. 51 Global rural setting hospitals market, 2016 - 2027 (USD Million)
  • FIG. 52 Global laboratories market, 2016 - 2027 (USD Million)
  • FIG. 53 Global urban setting laboratories market, 2016 - 2027 (USD Million)
  • FIG. 54 Global rural setting laboratories market, 2016 - 2027 (USD Million)
  • FIG. 55 Global assisted living healthcare facilities market, 2016 - 2027 (USD Million)
  • FIG. 56 Global urban setting assisted living healthcare facilities market, 2016 - 2027 (USD Million)
  • FIG. 57 Global rural setting assisted living healthcare facilities market, 2016 - 2027 (USD Million)
  • FIG. 58 Global home market, 2016 - 2027 (USD Million)
  • FIG. 59 Global others market, 2016 - 2027 (USD Million)
  • FIG. 60 Regional marketplace: Key takeaway
  • FIG. 61 Global C-reactive protein testing market regional outlook, 2019 & 2027
  • FIG. 62 North America C-reactive protein testing market, 2016 - 2027 (USD Million)
  • FIG. 63 U.S. C-reactive protein testing market, 2016 - 2027 (USD Million)
  • FIG. 64 Canada C-reactive protein testing market, 2016 - 2027 (USD Million)
  • FIG. 65 Europe C-reactive protein testing market, 2016 - 2027 (USD Million)
  • FIG. 66 Germany C-reactive protein testing market, 2016 - 2027 (USD Million)
  • FIG. 67 U.K. C-reactive protein testing market, 2016 - 2027 (USD Million)
  • FIG. 68 Asia Pacific C-reactive protein testing market, 2016 - 2027 (USD Million)
  • FIG. 69 Japan C-reactive protein testing market, 2016 - 2027 (USD Million)
  • FIG. 70 China C-reactive protein testing market, 2016 - 2027 (USD Million)
  • FIG. 71 Latin America C-reactive protein testing market, 2016-2027 (USD Million)
  • FIG. 72 Brazil C-reactive protein testing market, 2016 - 2027 (USD Million)
  • FIG. 73 Middle East & Africa C-reactive protein testing market, 2016 - 2027 (USD Million)
  • FIG. 74 South Africa C-reactive protein testing market, 2016 - 2027 (USD Million)
  • FIG. 75 Participant categorization
  • FIG. 76 Impact analysis by key companies
  • FIG. 77 Market position analysis for public companies
  • FIG. 78 Strategy framework